Recovery from leukopenia after discontinuation of clozapine does not exclude lymphoma
- 22 March 2024
- journal article
- editorial
- Published by Elsevier in Schizophrenia Research
- Vol. 267, 72-74
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring: Can the regulations be relaxed?Schizophrenia Research, 2023
- Hematological and Other Cancers in People Using ClozapineJournal of Clinical Psychopharmacology, 2023
- Long-term treatment with clozapine and other antipsychotic drugs and the risk of haematological malignancies in people with schizophrenia: a nationwide case-control and cohort study in FinlandThe Lancet Psychiatry, 2022
- Could N‐acetylcysteine improve the safety of clozapine?Human Psychopharmacology: Clinical and Experimental, 2020
- Clozapine-induced anemia: A case-report2020
- Haematologic malignancies associated with clozapine v. all other antipsychotic agents: a pharmacovigilance study in VigiBase®Psychological Medicine, 2020
- Clozapine induced pancytopenia leading to severe sepsis: an unusual early complicationBMC Research Notes, 2015
- Clozapine-induced blood dyscrasias in Saudi Arab patientsInternational Journal of Clinical Pharmacy, 2014
- Clozapine associated thrombocytopeniaJournal of Pharmacology and Pharmacotherapeutics, 2013
- Lymphocytopenia and Thrombocytopenia during Treatment with Risperidone or ClozapinePharmacopsychiatry, 1996